TG Therapeutics ( (TGTX) ) has released its Q4 earnings. Here is a breakdown of the information TG Therapeutics presented to its investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of novel treatments for B-cell diseases, with a focus on multiple sclerosis therapies.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue